What DKMS Life Science Lab does

DKMS Life Science Lab is a non-profit genotyping laboratory based in Dresden, Germany, founded in 1997 as part of the DKMS group, an international non-profit organization dedicated to fighting blood cancer and blood disorders. The laboratory specializes in high-resolution, sequence-based HLA (Human Leukocyte Antigen) typing to support stem cell donor matching, processing over 1 million potential donor samples annually and approximately 25,000 samples per week. Its customers include stem cell donor registries, transplant centers, hospitals, clinical hematologists, and research institutions worldwide, with named engagements including Dutch registry Matchis, US registry Gift of Life, and Universitätsklinikum Carl Gustav Carus Dresden.

The lab's core offerings are HLA Genotyping Service (covering HLA class I and II, NK cell receptors/KIR, blood groups, and other transplantation-relevant markers), CMV Status Service (non-invasive CMV IgG determination from buccal swabs, developed in 2017), and DNA Services for high-quality DNA extraction from customer samples. It uses Next Generation Sequencing with NGS Amplicon methods and in-house developed reagents, NGS Shotgun, rSSO Luminex assays with proprietary reagents, and Nanopore long-read sequencing. In 2013 it became the world's first HLA typing lab to deploy NGS in a high-throughput, highly parallelized manner. Through continuous refinement of long-read sequencing workflows it has fully characterized more than 10,000 novel HLA alleles submitted to the IPD-IMGT/HLA database by end of 2025. The lab holds DIN EN ISO 15189, EFI (European Federation for Immunogenetics), GMP, and ZKRD (Central Bone Marrow Donor Registry Germany) certifications and operates a digital Partner Area platform for client collaboration.

The company runs a B2B enterprise sales model with quote-based, multi-year contracts and personalized project offers. Engagement combines direct sales to registries, transplant centers, and research institutions with clinical laboratory services delivered to hematologists and transplant units. Revenue is not publicly disclosed, and the entity is structured as a gGmbH (gemeinnützige GmbH, a non-profit limited liability company) under the DKMS parent foundation, with around 180 employees. Marketing channels include scientific conferences (EFI, APHIA), peer-reviewed publications, and the Partner Area digital platform.

Name

DKMS Life Science Lab

Legal name

DKMS Life Science Lab gGmbH

Website

https://dkms-lab.de

Company type

Private

Founded year

1997

Operating status

Operating

Headcount range

51–100 employees

Short description

DKMS Life Science Lab is a Dresden-based non-profit HLA genotyping laboratory serving global stem cell donor registries, transplant centers, and hospitals. It types over 1 million donors annually and holds EFI and GMP certifications.

Ownership category

akta.pro rank

Product category

Genotyping Laboratory Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215)

SIC

Services-Medical Laboratories (8071), Services-Testing Laboratories (8734)

akta.pro primary industry

Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB)

akta.pro secondary industries

Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D) (HLAGAJAC), Bioinformatics, Multi-Omics Data Analysis & Interpretation Services (HLAGANAI), Lab Analytics, Utilization Management & Operational Intelligence (HLACAMAK)

Keywords

• HLA genotyping services
• Stem cell donor typing
• Immunogenetics laboratory
• CMV serostatus testing
• DNA extraction services

Headquarters

HQ city

Dresden

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Infrastructure, Operations, Supply Chain, Marketing or Sales

Revenue model

1. HLA Genotyping Services: High-resolution HLA typing services for stem cell donor registries, transplant centers, hospitals, and doctors. DNA extracted from blood or buccal swab samples is analyzed to determine exact genetic profiles of HLA genes essential for matching potential donors to patients needing stem cell transplantation.
2. CMV Status Service: Non-invasive oral sampling for CMV IgG determination from dried swabs. Provides CMV serostatus determination for donor registries.
3. DNA Services: Consistent sample processing for studies, delivering high-quality DNA extracted from customer-provided sample material.
4. Clinical Laboratory Services: Patient-associated typings including patient, relatives, and confirmatory typing of unrelated donors. Search unit performs donor searches for individual patients.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

DKMS Life Science Lab is a high-throughput immunogenetics laboratory that performs high-resolution HLA genotyping for stem cell donor registries, transplant centers, hospitals, and research institutions worldwide. Core services include HLA class I and class II genotyping (plus KIR and blood group markers), non-invasive CMV status determination from buccal swabs, and DNA extraction services, all delivered through a highly automated workflow using NGS, Nanopore, and rSSO Luminex technologies. The lab also operates the Partner Area digital platform for partner collaboration.

Product overview

DKMS Life Science Lab operates as a genotyping service laboratory offering three core services: HLA Genotyping Service for high-resolution molecular typing of HLA genes and related markers critical for stem cell donor matching; CMV Status Service for cytomegalovirus serostatus determination from non-invasive oral samples; and DNA Services for high-quality DNA extraction from customer samples. The company also provides a Partner Area platform for digital collaboration with clients. All services are delivered through a highly automated high-throughput laboratory workflow that processes approximately 7,000 samples daily.

Differentiator

Problem solved

Functional benefit

Products and services

• HLA Genotyping Service High-resolution molecular genotyping for HLA class I and class II, NK cell receptors (KIR), blood groups, and other genetic markers used for stem cell donor matching and transplantation compatibility. Delivered to stem cell donor registries, transplant centers, hospitals, doctors, and research institutions.
• CMV Status Service Non-invasive oral sampling for CMV IgG determination, deriving CMV serostatus from dried buccal swabs with good sensitivity and specificity. Supports donor assessment and transplantation planning for stem cell donor registries and clinicians.
• DNA Services Consistent sample processing for studies, delivering high-quality DNA extracted from customer-provided sample material for research and clinical studies.
• Clinical Laboratory Services (Patient-Associated Typings and Donor Searches) Clinical laboratory services for patients including patient HLA typings, related-donor typings, confirmatory typing of unrelated donors, and donor searches among relatives and unrelated potential donors via Search Unit Dresden (ZKRD certified).

Quantifiable outcome

• Over 1 million potential stem cell donors typed each year using NGS technology
• +2 more outcomes

Named customers8 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Four partnerships are on record, tiered core and minor.

• MatchiscoreStrategic or Co-development PartnerDutch stem cell donor registry collaborating with DKMS Life Science Lab for HLA genotyping services. One of numerous established strong collaborations with prestigious registries worldwide.
• Gift of LifecoreStrategic or Co-development PartnerUS stem cell donor registry collaborating with DKMS Life Science Lab for HLA genotyping services. Established strong collaboration as part of global registry network.
• Universitätsklinikum Carl Gustav Carus DresdencoreStrategic or Co-development PartnerRenowned scientific and research center with established collaboration with DKMS Life Science Lab for research projects in immunogenetics and blood cancer.
• Pharmaceutical CompaniesminorStrategic or Co-development PartnerEsteemed pharmaceutical companies collaborating with DKMS Life Science Lab for genotyping services and research projects.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Laboratory Corporation of America (LabCorp): LabCorp is one of the largest clinical laboratory networks in the world, providing a broad menu of diagnostic tests including HLA typing services through its specialty labs. A broad incumbent offering HLA typing as one of many diagnostics services.
• CareDx: CareDx is a transplant-focused diagnostics company offering AlloSure, AlloMap, and HLA-related services across the pre- and post-transplant continuum. A broader incumbent in transplant diagnostics with overlapping customer base of transplant centers.
• Eurofins Genomics: Eurofins Genomics provides DNA sequencing, genotyping, and bioinformatics services including HLA-related applications through its GenDx subsidiary. A broad incumbent in genomics services with overlapping HLA capabilities.
• One Lambda (Thermo Fisher Scientific): One Lambda, part of Thermo Fisher Scientific, is a leading provider of transplant diagnostics including HLA typing reagents, software, and services. Broader incumbent offering a wider portfolio across reagents and instruments compared with DKMS Life Science Lab's services focus.
• Quest Diagnostics: Quest Diagnostics is a major clinical laboratory services provider with transplant-related testing including HLA typing. A broad incumbent competing in HLA typing as part of a wider diagnostic portfolio.
• Immucor: Immucor is a transfusion and transplant diagnostics company providing HLA typing and antibody detection products. A broader incumbent that competes in HLA-related products serving hospital blood banks and transplant centers.

Emerging players

• ProImmune: ProImmune provides HLA tetramers, MHC peptide binding assays, and immunogenicity services for research and clinical applications. An emerging player with partial overlap in HLA-related services, focused more on research tools than registry-scale typing.

Others

• Bio-Rad Laboratories: Bio-Rad supplies HLA typing reagents, controls, and instruments used in immunogenetics laboratories worldwide. An adjacent player as a reagent and instrument provider serving HLA labs including DKMS Life Science Lab, rather than a direct service competitor.

Direct peers

• GenDx: GenDx (now part of Eurofins Genomics) provides HLA typing reagents and Sanger/NGS-based typing services for transplant diagnostics. Directly comparable to DKMS Life Science Lab as a specialty HLA typing services and reagents provider serving stem cell donor registries and transplant centers.
• Histogenetics: Histogenetics is an EFI-accredited HLA typing laboratory offering high-resolution HLA sequence-based typing services for transplant programs and donor registries. Directly competes with DKMS Life Science Lab in high-resolution HLA typing for stem cell donor matching.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks4 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/160741131230077
• LinkedInlinkedin.com/company/dkms-life-science-lab

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DKMS Life Science Lab